Dr. Frederick (Fritz) C. Eilber
Frederick (Fritz) C. Eilber, MD was raised in Santa Monica, California, where he received his
primary and secondary school education. Dr. Eilber graduated from the University of
Pennsylvania in 1989 with a BS in Biology. He received his MD degree from the University
of California, Los Angeles (UCLA) in 1995 and went on to complete his residency training in
General Surgery at the UCLA as well. As a research fellow during his residency, Dr. Eilber
developed an interest in sarcoma research that was further developed as a surgical oncology
fellow at Memorial Sloan-Kettering Cancer Canter (MSKCC) in New York, New York. In
2004, after completing a surgical oncology fellowship at MSKCC, Dr. Eilber returned to the
Department of Surgery at UCLA where he is currently chief of the Cancer Surgery Service
with a dual appointment in the Department of Molecular and Medical Pharmacology.
Dr. Eilber was specifically recruited back to the Division of Surgical Oncology at UCLA to
take over the leadership of the UCLA Sarcoma Program, with the goal of developing a
translational research program to compliment its clinical prominence. This program has
become the UCLA Sarcoma Clinical / Translational Research Program within the Jonnson
Comprehensive Cancer Center (JCCC) and a Program Area in the Institute of Molecular
Medicine. Dr. Eilber is director of both of these Sarcoma Program Areas.
Dr. Eilber’s sarcoma research is focused on translating molecular oncology from the
laboratory to the clinic in a rapid and clinically relevant manner with the goal of swiftly
impacting patient care. His long-term objective is to rationally apply molecularly targeted
therapies in the context of defined genetic lesions thus developing effective and
individualized therapeutic strategies for patients with sarcoma. His efforts have recently
focused on applying molecular imaging to evaluate response to systemic therapy (traditional
chemotherapy, targeted therapy) and direct regional therapies (surgery, radiation therapy,
embolization) in sarcoma.